
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5415949
[patent_doc_number] => 20090041836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Glycolipopeptide and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/217376
[patent_app_country] => US
[patent_app_date] => 2008-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 33241
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041836.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217376 | Glycolipopeptide antibodies | Jul 2, 2008 | Issued |
Array
(
[id] => 161700
[patent_doc_number] => 07670598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-02
[patent_title] => 'Method for limiting the growth of cancer cells using an attenuated measles virus'
[patent_app_type] => utility
[patent_app_number] => 12/135721
[patent_app_country] => US
[patent_app_date] => 2008-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 5
[patent_no_of_words] => 9940
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/670/07670598.pdf
[firstpage_image] =>[orig_patent_app_number] => 12135721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/135721 | Method for limiting the growth of cancer cells using an attenuated measles virus | Jun 8, 2008 | Issued |
Array
(
[id] => 4718640
[patent_doc_number] => 20080241162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'HUMAN MONOCLONAL ANTIBODY FAB FRAGMENTS DIRECTED AGAINST HCV E2 GLYCOPROTEIN AND ENDOWED WITH IN VITRO NEUTRALIZING ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/128344
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4769
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241162.pdf
[firstpage_image] =>[orig_patent_app_number] => 12128344
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/128344 | Human monoclonal antibody Fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity | May 27, 2008 | Issued |
Array
(
[id] => 4681831
[patent_doc_number] => 20080248057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation'
[patent_app_type] => utility
[patent_app_number] => 12/153540
[patent_app_country] => US
[patent_app_date] => 2008-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7406
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248057.pdf
[firstpage_image] =>[orig_patent_app_number] => 12153540
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/153540 | Multivalent immunogenic composition containing RSV subunit compostion and influenza virus preparation | May 20, 2008 | Abandoned |
Array
(
[id] => 6525622
[patent_doc_number] => 20100203506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'VIRAL VARIANTS AND METHODS FOR DETECTING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/117869
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7761
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203506.pdf
[firstpage_image] =>[orig_patent_app_number] => 12117869
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/117869 | VIRAL VARIANTS AND METHODS FOR DETECTING SAME | May 8, 2008 | Abandoned |
Array
(
[id] => 5520922
[patent_doc_number] => 20090028903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'Novel use'
[patent_app_type] => utility
[patent_app_number] => 12/148095
[patent_app_country] => US
[patent_app_date] => 2008-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 67503
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20090028903.pdf
[firstpage_image] =>[orig_patent_app_number] => 12148095
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/148095 | Novel use | Apr 15, 2008 | Abandoned |
Array
(
[id] => 5385244
[patent_doc_number] => 20090226489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'VIRAL VACCINE COMPOSITION, PROCESS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/102564
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27107
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226489.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102564
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102564 | Viral vaccine composition, process and methods of use | Apr 13, 2008 | Issued |
Array
(
[id] => 5458727
[patent_doc_number] => 20090258879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'METHOD FOR TREATING CANCER, RHEUMATOID ARTHRITIS AND OTHER MEDICAL DISEASES BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT MEDICATIONS INTO TARGETED CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/101966
[patent_app_country] => US
[patent_app_date] => 2008-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5127
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258879.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101966 | METHOD FOR TREATING CANCER, RHEUMATOID ARTHRITIS AND OTHER MEDICAL DISEASES BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT MEDICATIONS INTO TARGETED CELLS | Apr 11, 2008 | Abandoned |
Array
(
[id] => 151570
[patent_doc_number] => 07678569
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-16
[patent_title] => 'Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/061504
[patent_app_country] => US
[patent_app_date] => 2008-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15076
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/678/07678569.pdf
[firstpage_image] =>[orig_patent_app_number] => 12061504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/061504 | Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof | Apr 1, 2008 | Issued |
Array
(
[id] => 4765008
[patent_doc_number] => 20080176219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Assay to detect HCV receptor binding'
[patent_app_type] => utility
[patent_app_number] => 12/077367
[patent_app_country] => US
[patent_app_date] => 2008-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5978
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176219.pdf
[firstpage_image] =>[orig_patent_app_number] => 12077367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/077367 | Assay to detect HCV receptor binding | Mar 17, 2008 | Abandoned |
Array
(
[id] => 6228914
[patent_doc_number] => 20100183652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS'
[patent_app_type] => utility
[patent_app_number] => 12/049097
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 32067
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183652.pdf
[firstpage_image] =>[orig_patent_app_number] => 12049097
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/049097 | STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS | Mar 13, 2008 | Abandoned |
Array
(
[id] => 4764648
[patent_doc_number] => 20080175859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/047787
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 24966
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175859.pdf
[firstpage_image] =>[orig_patent_app_number] => 12047787
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/047787 | Recombinant infectious laryngotracheitis virus and uses thereof | Mar 12, 2008 | Issued |
Array
(
[id] => 4752436
[patent_doc_number] => 20080160509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'ASSAYS FOR PREDICTING AND ASSESSING PREDISPOSITION TO MALE PATTERN BALDNESS'
[patent_app_type] => utility
[patent_app_number] => 12/048139
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6410
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20080160509.pdf
[firstpage_image] =>[orig_patent_app_number] => 12048139
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/048139 | ASSAYS FOR PREDICTING AND ASSESSING PREDISPOSITION TO MALE PATTERN BALDNESS | Mar 12, 2008 | Abandoned |
Array
(
[id] => 4751974
[patent_doc_number] => 20080160047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'OIL IN WATER EMULSIONS CONTAINING SAPONINS'
[patent_app_type] => utility
[patent_app_number] => 12/020719
[patent_app_country] => US
[patent_app_date] => 2008-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 11723
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20080160047.pdf
[firstpage_image] =>[orig_patent_app_number] => 12020719
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/020719 | OIL IN WATER EMULSIONS CONTAINING SAPONINS | Jan 27, 2008 | Abandoned |
Array
(
[id] => 4955401
[patent_doc_number] => 20080188425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 12/009844
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13220
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20080188425.pdf
[firstpage_image] =>[orig_patent_app_number] => 12009844
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/009844 | Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods | Jan 21, 2008 | Abandoned |
Array
(
[id] => 5580485
[patent_doc_number] => 20090175831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'ADAPTABLE MESSENGER RIBONUCLEIC ACID MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS'
[patent_app_type] => utility
[patent_app_number] => 11/969887
[patent_app_country] => US
[patent_app_date] => 2008-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6046
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175831.pdf
[firstpage_image] =>[orig_patent_app_number] => 11969887
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/969887 | ADAPTABLE MESSENGER RIBONUCLEIC ACID MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS | Jan 4, 2008 | Abandoned |
Array
(
[id] => 111893
[patent_doc_number] => 07718610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Retrocyclins: antiviral and antimicrobial peptides'
[patent_app_type] => utility
[patent_app_number] => 11/968178
[patent_app_country] => US
[patent_app_date] => 2008-01-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 19024
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718610.pdf
[firstpage_image] =>[orig_patent_app_number] => 11968178
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/968178 | Retrocyclins: antiviral and antimicrobial peptides | Dec 31, 2007 | Issued |
Array
(
[id] => 4851973
[patent_doc_number] => 20080317715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'ANTI-BACTERIAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/963899
[patent_app_country] => US
[patent_app_date] => 2007-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6405
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20080317715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11963899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/963899 | ANTI-BACTERIAL AGENTS | Dec 23, 2007 | Abandoned |
Array
(
[id] => 4807489
[patent_doc_number] => 20080171067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites'
[patent_app_type] => utility
[patent_app_number] => 11/961436
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11502
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171067.pdf
[firstpage_image] =>[orig_patent_app_number] => 11961436
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/961436 | Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites | Dec 19, 2007 | Abandoned |
Array
(
[id] => 4676165
[patent_doc_number] => 20080213795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes'
[patent_app_type] => utility
[patent_app_number] => 12/004053
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12848
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213795.pdf
[firstpage_image] =>[orig_patent_app_number] => 12004053
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/004053 | DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes | Dec 19, 2007 | Abandoned |